Financhill
Sell
50

CATX Quote, Financials, Valuation and Earnings

Last price:
$2.7700
Seasonality move :
28.22%
Day range:
$2.6800 - $2.7650
52-week range:
$1.6000 - $5.3881
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
186.46x
P/B ratio:
0.84x
Volume:
561.5K
Avg. volume:
1.5M
1-year change:
-13.79%
Market cap:
$204.4M
Revenue:
$1.5M
EPS (TTM):
-$1.46

CATX Analysts' Consensus Rating

The 13 analysts providing 12-month price projections for Perspective Therapeutics, Inc. shares anticipate an average target of $12.3077, ranging from a low estimate of $4.0000 to a high estimate of $20.0000. This average target implies a growth of 347.55% compared to the current stock price of $2.7500.

Consensus Price Target

$12.3077

Highest Price Target

$20.0000

Lowest Price Target

$4.0000

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 10 12 12

Hold 1 1 1

Sell 0 0 0
Consensus Buy Buy Buy

CATX Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 2

Corcept Therapeutics, Inc. [CORT] is up 5.75% over the past day.

Buy
75
AXSM alert for Jan 2

Axsome Therapeutics, Inc. [AXSM] is down 3.49% over the past day.

Sell
50
NUTX alert for Jan 2

Nutex Health, Inc. [NUTX] is down 8.95% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock